MedPath

Effect of oxygen therapy in preventing contrast nephropathy

Phase 3
Conditions
Coronary artery disease.
Acute ischemic heart disease, unspecified
Registration Number
IRCT20190317043082N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
204
Inclusion Criteria

Male or female patients over 35 years old
Suspected of coronary artery disease

Exclusion Criteria

Arterial oxygen saturation less than 90%
Having end stage renal disease
Patients undergoing dialysis
coronary artery bypass surgery
Candidate for emergency coronary artery bypass surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine level. Timepoint: Before the procedure and 48 hours later. Method of measurement: Blood sampling.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath